About Medeloop
Medeloop is a company based in Palo Alto (United States) founded in 2021 by Rene Caissie. Medeloop has raised $23.5 million across 2 funding rounds from investors including Icon Ventures, Inovia Capital and General Catalyst. Medeloop offers products and services including Analytics Genius, Studies Genius, and Grants Genius. Medeloop operates in a competitive market with competitors including Pure Biologics, Hyku Biosciences, Sirion Biotech, Taizhou Baiying Biotechnology and Centivax, among others.
- Headquarter Palo Alto, United States
- Founders Rene Caissie
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medeloop Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.5 M (USD)
in 2 rounds
-
Latest Funding Round
$15.5 M (USD), Series A
Oct 04, 2024
-
Investors
Icon Ventures
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medeloop
Medeloop offers a comprehensive portfolio of products and services, including Analytics Genius, Studies Genius, and Grants Genius.
AI tool for analyzing datasets without coding and extracting insights
Platform for collecting, monitoring, and automating study data
AI for matching grants and generating proposals quickly
People of Medeloop
Unlock access to complete
Funding Insights of Medeloop
Medeloop has successfully raised a total of $23.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $15.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medeloop
Medeloop has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Icon Ventures, Inovia Capital and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage technology companies by Inovia Capital.
|
Locked | Locked | Locked | |
|
Sector-agnostic growth stage VC investment company funding companies in the US and Asia
|
Locked | Locked | Locked | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked |
Investor details for Medeloop
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medeloop
Investment portfolio details for Medeloop
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medeloop
Detailed financials for Medeloop
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medeloop Comparisons
Peer comparison for Medeloop
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medeloop
Medeloop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pure Biologics, Hyku Biosciences, Sirion Biotech, Taizhou Baiying Biotechnology and Centivax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Specialized CRO with expertise in recombinant protein production and purification
|
|
| Locked | Locked | Locked |
Covalent medicines platform is advanced for drug discovery targeting proteins.
|
|
| Locked | Locked | Locked |
Customized AAV-based viral vectors for gene therapy are supplied.
|
|
| Locked | Locked | Locked |
Antibody-drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical and biotech clients.
|
Detailed competitors of Medeloop
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medeloop
Complete news archive for Medeloop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medeloop
Medeloop was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Medeloop is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Rene Caissie is the current CEO of Medeloop. They have also founded this company.
Medeloop is a funded company, having raised a total of $23.5M across 2 funding rounds to date.
Medeloop was established in 2021 in Palo Alto, United States, as a contract research organization in the biotechnology sector. Drug discovery services are provided to support pharmaceutical development. Operations are centered on advancing research processes for clients. The company is led by co-founder and CEO Rene Caissie. Focus remains on efficient, data-driven solutions in the life sciences field.
Medeloop's top competitors include Pure Biologics, Centivax and Sirion Biotech.
Medeloop offers Analytics Genius, Studies Genius, and Grants Genius.
Medeloop has 10 investors. Key investors include Icon Ventures, Inovia Capital, General Catalyst, Maven Ventures, and Healthier Capital.